about
Small molecule R1498 as a well-tolerated and orally active kinase inhibitor for hepatocellular carcinoma and gastric cancer treatment via targeting angiogenesis and mitosis pathwaysHeat shock protein 25-enriched plasma transfusion preconditions the heart against doxorubicin-induced dilated cardiomyopathy in mice.Interaction index and different methods for determining drug interaction in combination therapy.An anticancer strategic dilemma: to kill or to contain. The choice of the pharmaceutical industry in 2009.
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Role of novel targeted therapies in the clinic.
@ast
Role of novel targeted therapies in the clinic.
@en
type
label
Role of novel targeted therapies in the clinic.
@ast
Role of novel targeted therapies in the clinic.
@en
prefLabel
Role of novel targeted therapies in the clinic.
@ast
Role of novel targeted therapies in the clinic.
@en
P2860
P356
P1476
Role of novel targeted therapies in the clinic.
@en
P2093
R S Herbst
P2860
P2888
P356
10.1038/SJ.BJC.6602605
P407
P478
92 Suppl 1
P577
2005-06-01T00:00:00Z